siRNA核酸药物的发展,机遇和挑战
Bowen Xiao1, Shaopeng Wang2, Yu Pan1
1MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Molecular therapy. Nucleic acids
|February 3, 2025
概括
20多年来开发的小干扰RNA (siRNA) 药物提供了有效的基因沉默. 虽然向肝脏的疗法已获得批准,但肝外输送仍然是广泛siRNA药物应用的关键挑战.
科学领域:
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 小干扰RNA (siRNA) 药物利用RNA干扰进行转录后基因沉默.
- 超过二十年的开发已经导致美国FDA对六种siRNA治疗药物的市场批准.
- 目前批准的siRNA药物显示出高疗效,低剂量和不频繁的使用,获得了显著的关注.
研究的目的:
- 审查siRNA药物的历史发展和机制.
- 专注于已批准和正在研究的siRNA疗法的药物标,说明和临床试验结果.
- 分析siRNA药物的关键商业化阶段.
主要方法:
- 关于siRNA药物开发历史的文献综述.
- 已批准的siRNA药物的分析,包括目标,适应症和临床试验数据.
- 对siRNA治疗药物的商业化过程的检查.
主要成果:
- 已经批准了六种针对肝脏的siRNA药物 (帕蒂西兰,吉沃西兰,卢马西兰,武特里西兰,英克利西兰,内多西兰).
- siRNA药物表现出有效性,需要低剂量和不频繁的使用.
- 肝外药物输送仍然是siRNA治疗的重要障碍.
结论:
- siRNA药物具有巨大的治疗潜力,可以使各种向基因沉默.
- 目前批准的所有siRNA药物都是针对肝脏的,利用器官独特的生理特性.
- 交付系统的进一步进步对于扩大siRNA药物的肝脏以外的临床应用至关重要.
相关概念视频
02:30siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
02:30Small interfering RNAs (siRNA)
3.5K
3.5K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
01:23RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
02:57piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K